Toon Overbeeke, Vitestro’s Co-Founder and Chief Executive Officer adds:“We have spent nearly five years on the development of this breakthrough medical device. All relevant disciplines are represented in our dedicated, specialized team of 35 people. To prepare for production and commercialization, the team will double in size in the next two years. We have clear momentum in the market and will be the first to bring autonomous technology to European hospitals. With our technology we can help to build a more robust and resilient healthcare system.” Anja Leyte, Director OLVG Laboratories, participating in clinical studies commented: “By introducing automated blood drawing, high quality as well as capacity is guaranteed in our laboratories. Vitestro’s technology helps solving staffing shortages at our blood drawing department and improving sample standardization. Patients are also very enthusiastic."
- E N D S -About Vitestro
In 2017 Vitestro’s founders rose to the challenge to create a better blood drawing experience. Today Vitestro is well underway to achieve its goal with a committed team of 35 highly skilled people with a track record in medical robotics, imaging software, AI, QA/RA and business development. Vitestro is based in Utrecht, the Netherlands. Vitestro is well funded by private investors and government subsidies.
Please contact for more information:
Vitestro, Utrecht, the Netherlands
Toon Overbeeke, Chief Executive Officer, Co-founder,
T: +31 30 2004551
LifeSpring Life Sciences Communication
T: +31 6 538 16 427